PTSD Trial, Recruiting (NCT05674617)

PTSD Trial, Recruiting NCT05674617 Sponsor: VA Office of Research and Development Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT05674617 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are currently receiving outpatient mental health care through the VA Maryland Health Care System (this includes general mental health clinics, recovery centers, intensive case management programs, or PTSD treatment teams)
You have been diagnosed with PTSD, confirmed through a specific structured interview used by clinicians
You have also been diagnosed with a serious mental illness, such as a psychotic disorder or bipolar disorder, as shown in your medical records
You have regular access to a telephone

Who may not be able to join:

You are currently struggling with moderate to severe substance use in a way that would affect your ability to take part in the study or that would mean you need a more intensive level of care
You are currently taking part in a specific type of trauma-focused therapy for PTSD (such as Written Exposure Therapy, Cognitive Processing Therapy, Prolonged Exposure, or EMDR), or you completed one of these therapies within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary K Howell, PhD, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Phone: (410) 605-7000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05674617

Sponsor: VA Office of Research and Development

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: (410) 605-7000

More information: https://clinicaltrials.gov/study/NCT05674617

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are currently receiving outpatient mental health care through the VA Maryland Health Care System (this includes general mental health clinics, recovery centers, intensive case management programs, or PTSD treatment teams)
You have been diagnosed with PTSD, confirmed through a specific structured interview used by clinicians
You have also been diagnosed with a serious mental illness, such as a psychotic disorder or bipolar disorder, as shown in your medical records
You have regular access to a telephone

Who may not be able to join:

You are currently struggling with moderate to severe substance use in a way that would affect your ability to take part in the study or that would mean you need a more intensive level of care
You are currently taking part in a specific type of trauma-focused therapy for PTSD (such as Written Exposure Therapy, Cognitive Processing Therapy, Prolonged Exposure, or EMDR), or you completed one of these therapies within the past 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

VA Office of Research and Development

Registry

ClinicalTrials.gov

Start date

1 December 2023

Est. completion

31 March 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants eligible divided by Individuals approached for recruitment; Client Satisfaction Questionnaire (CSQ-8); Retention and adherence rates; Mean number of sessions attended; Treatment dropout percentage

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov